Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Neonmind Biosciences Inc (OP: NMDBF ) N/A UNCHANGED Last Price Updated: 10:22 AM EST, Dec 14, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.0076 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them August 30, 2022 The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business... Via Benzinga Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved April 25, 2022 Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami... Via Benzinga Performance More News Read More NeonMind To Improve Patient Care And Data Management With Thrive Health's Digital Healthcare Platform April 22, 2022 Via Benzinga NeonMind To Launch 10 Mental Health Clinics In Canada, How Will Patients Benefit? April 13, 2022 Via Benzinga NeonMind Announces Plan to Launch 10 Clinics for Innovative Treatments as Mental Health Crisis Grows April 12, 2022 From NeonMind Biosciences Inc. Via AccessWire Psyched: Third Michigan City Decriminalizes Psychedelics, MindMed Reports $133M Cash Position, Real Brands To Enter The Space March 29, 2022 Via Benzinga NeonMind Files Provisional Patent Application For Psilocybin Induced Weight Loss March 22, 2022 Via Benzinga Psyched: Albert Labs Goes Public, Ex-Moderna Executive Joins MAPS, Novamind and Usona Join For Phase 2 Psilocybin Trial March 15, 2022 Via Benzinga NeonMind Completes Pre-IND Consultation With FDA And Strengthens Medical Services Division March 10, 2022 Via Benzinga Psyched: First Australian Psych Company On Nasdaq, Utah's Psychedelics Bill, LSD Vs. Psilocybin Study Unprecedented Results March 07, 2022 Via Benzinga NeonMind Teams Up With BioScript Solutions To Expand Its Clinic Network For Interventional Psychiatry Treatments March 03, 2022 Via Benzinga Cannabis Movers & Shakers: MedMen, Organigram, NeonMind, Green Check Verified February 24, 2022 Via Benzinga NeonMind Appoints Dr. Dinesh Bhayana As Site Medical Director Of Its First Mental Health Clinic February 24, 2022 Via Benzinga NeonMind To Open Its First Specialty Mental Health Clinic In Ontario, More To Come February 17, 2022 Via Benzinga Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th February 09, 2022 Via Benzinga NeonMind to Present at H.C. Wainwright 2nd Annual Psychedelics Virtual Conference December 02, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property NeonMind Announces Successful Completion of Pre-IND Consultation with FDA on Clinical Path for Obesity Drug Candidate NEO-001 November 23, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety NeonMind to Participate in Panel Discussion at Lift & Co. Expo's Psychedelics Business Summit on November 19, 2021 November 17, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Cannabis Intellectual Property Exposures Cannabis Intellectual Property NeonMind and SRx Health Solutions Announce Strategic Alliance to Establish Specialty Mental Health Clinics for Interventional Psychiatry Treatments November 08, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property NeonMind Biosciences Named as a Top Industry Innovator in Inaugural Issue of Psychedelia Magazine November 05, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property NeonMind Advances Strategy for Specialty Clinic Launch September 28, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation October 18, 2021 Via Benzinga NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhD. September 22, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are October 13, 2021 Via Benzinga NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board September 16, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.